(FATE) Fate Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Fate Therapeutics | (FATE) share price targets
Complete technical analysis of Fate Therapeutics (FATE) by charts plus indicators, forecast predictions and share price targets for Fate Therapeutics (FATE)
Fate Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-10-23 View latest technical analysis
10 day averaged volume of Fate Therapeutics is 990040
| Date | Daily Closing Price | Open | High | Low | Volume |
| 23 Wed Oct 2024 | 3.03 | 3.17 | 3.21 | 3.00 | 1.063 times |
| 22 Tue Oct 2024 | 3.19 | 3.14 | 3.24 | 3.08 | 0.616 times |
| 21 Mon Oct 2024 | 3.15 | 3.21 | 3.25 | 3.08 | 1.864 times |
| 18 Fri Oct 2024 | 3.23 | 3.23 | 3.32 | 3.19 | 0.748 times |
| 17 Thu Oct 2024 | 3.22 | 3.19 | 3.27 | 3.11 | 0.761 times |
| 16 Wed Oct 2024 | 3.21 | 3.07 | 3.25 | 2.99 | 1.344 times |
| 15 Tue Oct 2024 | 3.05 | 3.05 | 3.13 | 2.95 | 0.735 times |
| 14 Mon Oct 2024 | 3.05 | 3.06 | 3.10 | 3.02 | 0.784 times |
| 11 Fri Oct 2024 | 3.09 | 2.96 | 3.10 | 2.93 | 1.053 times |
| 10 Thu Oct 2024 | 2.94 | 2.96 | 2.97 | 2.85 | 1.05 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 3 as stoploss in an intra day buy trade for a target of 3.19. However, stock will show a bearish move below 3.
Share price targets for Fate Therapeutics (FATE)
| Target Type | Value |
| Downside Target | 2.85 |
| Downside Target | 2.95 |
| Upside Target | 3.20 |
| Upside Target | 3.38 |
| Upside Target | 3.47 |
| Upside Target | 3.80 |
| Upside Target | 3.90 |
| Upside Target | 4.19 |
| Upside Target | 4.20 |
| Upside Target | 5.49 |
| Upside Target | 5.92 |
Intraday share price targets for Fate Therapeutics (FATE)
| Target Type | Value |
| Downside Intraday Target | 2.94 |
| Downside Intraday Target | 2.84 |
| Upside Intraday Target | 3.19 |
| Upside Intraday Target | 3.34 |
| Upside Intraday Target | 3.09 |
Weekly technical analysis of Fate Therapeutics (FATE)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 23 Wed Oct 2024 | 3.03 | 3.21 | 3.25 | 3.00 | 0.81 times |
| 18 Fri Oct 2024 | 3.23 | 3.06 | 3.32 | 2.95 | 0.594 times |
| 11 Fri Oct 2024 | 3.09 | 3.18 | 3.27 | 2.85 | 1.38 times |
| 04 Fri Oct 2024 | 3.22 | 3.59 | 3.80 | 3.06 | 1.288 times |
| 27 Fri Sep 2024 | 3.57 | 3.90 | 3.90 | 3.38 | 0.624 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Fate Therapeutics (FATE)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 23 Wed Oct 2024 | 3.03 | 3.47 | 3.47 | 2.85 | 0.947 times |
| 30 Mon Sep 2024 | 3.50 | 3.65 | 4.20 | 3.33 | 0.547 times |
| 30 Fri Aug 2024 | 3.67 | 5.35 | 5.49 | 3.20 | 0.814 times |
| 31 Wed Jul 2024 | 5.33 | 3.30 | 5.92 | 3.03 | 0.977 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Fate Therapeutics (FATE)
Price action analysis of Fate Therapeutics ( (FATE) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Fate Therapeutics ( (FATE) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Fate Therapeutics ( (FATE) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Fate Therapeutics ( (FATE) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Fate Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Fate Therapeutics in short term but the buy signal is initial and weak.
Fate Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Fate Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Fate Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.12 and Fate Therapeutics (FATE) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Fate Therapeutics (FATE) stock. Volume based technical analysis of Fate Therapeutics (FATE) stock is negative.
Fate Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Fate Therapeutics ( (FATE) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Fate Therapeutics ( (FATE) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Fate Therapeutics ( (FATE) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Fate Therapeutics ( (FATE) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Fate Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Fate Therapeutics in short term but the buy signal is initial and weak.
Fate Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Fate Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Fate Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.12 and Fate Therapeutics (FATE) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Fate Therapeutics (FATE) stock. Volume based technical analysis of Fate Therapeutics (FATE) stock is negative.
Fate Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.